Literature DB >> 31660302

Wearable cardioverter defibrillators: dead on arrival or chance of survival?

Pooja S Jagadish1, Rami N Khouzam2.   

Abstract

Year:  2019        PMID： 31660302      PMCID： PMC6787382          DOI： 10.21037/atm.2019.07.04

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  15 in total

Review 1.  Indications and use of the wearable cardiac defibrillator.

Authors:  Parikshit S Sharma; Pierre Bordachar; Kenneth A Ellenbogen
Journal:  Eur Heart J       Date:  2017-01-21       Impact factor: 29.983

2.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Authors:  Mina K Chung; Steven J Szymkiewicz; Mingyuan Shao; Edwin Zishiri; Mark J Niebauer; Bruce D Lindsay; Patrick J Tchou
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

Review 3.  Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association.

Authors:  Jonathan P Piccini; Larry A Allen; Peter J Kudenchuk; Richard L Page; Manesh R Patel; Mintu P Turakhia
Journal:  Circulation       Date:  2016-03-28       Impact factor: 29.690

Review 4.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  J Am Coll Cardiol       Date:  2018-08-16       Impact factor: 24.094

5.  The impact of body mass index on the wearable cardioverter defibrillator shock efficacy and patient wear time.

Authors:  Chingping Wan; Steven J Szymkiewicz; Helmut U Klein
Journal:  Am Heart J       Date:  2017-01-19       Impact factor: 4.749

6.  Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Authors:  Jeffrey E Olgin; Mark J Pletcher; Eric Vittinghoff; Jerzy Wranicz; Rajesh Malik; Daniel P Morin; Steven Zweibel; Alfred E Buxton; Claude S Elayi; Eugene H Chung; Eric Rashba; Martin Borggrefe; Trisha F Hue; Carol Maguire; Feng Lin; Joel A Simon; Stephen Hulley; Byron K Lee
Journal:  N Engl J Med       Date:  2018-09-27       Impact factor: 91.245

7.  Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD.

Authors:  Arthur M Feldman; Helmut Klein; Patrick Tchou; Srinivas Murali; W Jackson Hall; Donna Mancini; John Boehmer; Mark Harvey; M Stephen Heilman; Steven J Szymkiewicz; Arthur J Moss
Journal:  Pacing Clin Electrophysiol       Date:  2004-01       Impact factor: 1.976

Review 8.  Misunderstood or Mistrusted? The Under-Utilization of the Wearable Cardioverter Defibrillator in Clinical Practice.

Authors:  Pooja S Jagadish; Mariana Aziz; Viswanatha Chinta; Rami N Khouzam
Journal:  Curr Probl Cardiol       Date:  2018-09-18       Impact factor: 5.200

Review 9.  Wearable cardioverter defibrillator: a life vest till the life boat (ICD) arrives.

Authors:  Johnson Francis; Sven Reek
Journal:  Indian Heart J       Date:  2014-01-08

10.  Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study.

Authors:  Korbinian Lackermair; Christoph G Schuhmann; Michaela Kubieniec; Lisa M Riesinger; Ina Klier; Thomas J Stocker; Stefan Kääb; Heidi L Estner; Stephanie Fichtner
Journal:  Biomed Res Int       Date:  2018-06-27       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.